What Is an Acute Exacerbation of Bronchitis?

An Acute Exacerbation of Bronchitis (AEB) is a swift deterioration in the condition of a person living with chronic bronchitis. It is defined by an abrupt worsening of usual respiratory symptoms that requires a modification of regular therapy. Chronic bronchitis is a component of Chronic Obstructive Pulmonary Disease (COPD), a progressive lung condition, making AEB a common and concerning complication. The sudden increase in breathing difficulty, cough, and mucus production places significant strain on the respiratory system. Recognizing the signs and seeking prompt medical attention is necessary to prevent a decline in lung function and avoid hospitalization.

Understanding Acute Exacerbation of Bronchitis

Chronic bronchitis is characterized by a persistent cough that produces sputum, usually for a minimum of three months a year for two consecutive years. This ongoing state involves inflammation and irritation of the bronchial tubes, causing them to produce excess mucus. For a patient with this long-term condition, the acute exacerbation signifies a deviation from their typical, stable baseline.

This acute event involves symptoms becoming worse than the usual day-to-day variation, often lasting several days. The airways narrow further due to increased inflammation and the secretion of a larger volume of thicker mucus. This rapid escalation of symptoms is one of the most frequent reasons why patients require emergency care or admission to a hospital. Each exacerbation can cause additional, potentially irreversible damage to the lungs, making them a significant factor in the overall progression of the underlying disease. The goal of medical management is to return the patient to their previous state of health and lung function.

Identifying Common Triggers and Symptoms

The primary causes of an acute exacerbation are typically respiratory infections or increased exposure to environmental irritants. Respiratory tract infections account for approximately half of all exacerbations, with viruses being the most frequent culprits. Common viruses that cause the cold or flu, such as human rhinovirus, influenza, and parainfluenza, are often the initial triggers.

Bacterial infections are also significant causes, accounting for a large portion of the remaining cases, and sometimes co-existing with a viral infection. Common bacteria include Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis. Beyond infectious agents, exposure to pollutants, dust, and tobacco smoke can trigger an acute episode by increasing inflammation in the already-sensitive airways.

Anthonisen Criteria

The signs that an exacerbation is occurring are often described using the Anthonisen criteria, which focus on three cardinal symptoms:

  • Increase in shortness of breath (dyspnea)
  • Increase in the total volume of sputum produced
  • Increase in the purulence or thickness of the sputum

Sputum purulence refers to a change in the color of the mucus to yellow or green, which suggests a higher concentration of white blood cells and often indicates an infection. The presence of all three symptoms indicates a severe exacerbation, while two symptoms, especially increased purulence, suggest a moderate episode. Worsened shortness of breath is frequently the most distressing symptom for the patient, as it directly impacts their ability to perform daily activities.

How Doctors Assess an Exacerbation

When a patient seeks care for a potential exacerbation, the medical assessment process focuses on confirming the diagnosis and determining the severity of the lung impairment. The evaluation begins with a physical examination, where the doctor listens for new or increased wheezing and crackling sounds, suggesting airflow obstruction and fluid buildup. Oxygen saturation levels are checked using a pulse oximeter; a lower-than-normal reading may signal the need for immediate oxygen therapy.

To rule out other serious conditions that can mimic an exacerbation, such as pneumonia or heart failure, a chest X-ray is commonly performed. The X-ray provides a visual image of the lungs and identifies signs of consolidation or collapse indicative of a bacterial infection. For more severe cases or signs of respiratory failure, an arterial blood gas test is conducted. This test measures the oxygen and carbon dioxide levels in the blood, providing a precise assessment of gas exchange function and the degree of respiratory distress.

If an infection is suspected, a sputum sample may be collected for culture. Sputum culture identifies the specific bacteria present and determines which antibiotics will be most effective. Blood tests for specific biomarkers, such as C-reactive protein (CRP) or procalcitonin, also help guide treatment by indicating the likelihood of a bacterial infection.

Current Treatment Protocols

The immediate management of an acute exacerbation involves a multimodal approach aimed at reducing airway inflammation, opening the bronchial tubes, and treating any underlying infection. Bronchodilators are a cornerstone of therapy, often given via a nebulizer or an increased dose of the patient’s existing inhaler. These medications quickly relax the muscles around the airways, widening the bronchial tubes to ease airflow.

Systemic corticosteroids, such as oral prednisone, are administered to significantly reduce the inflammation within the airways. A short course of these anti-inflammatory medications is highly effective in improving lung function and shortening recovery time. The duration of steroid therapy is typically limited to minimize potential side effects.

Antibiotics are prescribed if there is strong evidence of a bacterial infection, particularly in cases meeting all three Anthonisen criteria or if the patient is severely ill. Even when the infectious agent is not yet confirmed by a culture, doctors may initiate empiric antibiotic treatment based on symptom severity and the purulent nature of the sputum. The goal is to quickly eliminate common bacterial pathogens before the infection can worsen.

Supportive care includes supplemental oxygen for those experiencing low oxygen saturation. For individuals in severe respiratory distress who fail to improve with initial medications, non-invasive or invasive mechanical ventilation may be necessary to assist with the work of breathing. These interventions ensure the patient receives adequate oxygen while the medications work to resolve the underlying exacerbation.